首页 > 最新文献

Immunology letters最新文献

英文 中文
Interaction between IL-23/Th17 immune inflammatory axis and intestinal flora in gastric mucosal atrophy caused by Helicobacter pylori infection in the elderly 老年人幽门螺杆菌感染所致胃黏膜萎缩中IL-23/Th17免疫炎症轴与肠道菌群的相互作用
IF 2.8 4区 医学 Q3 IMMUNOLOGY Pub Date : 2025-11-24 DOI: 10.1016/j.imlet.2025.107114
Haiping Shen, Shuyuan Zhu, Lingling Ren, Fangling Chen, Chengyong Qian, Xiangcheng Hu, Guanglan Chen

Objective

To explore the interactive effects of the interleukin-23 (IL-23)/Th17 immune-inflammatory axis and gut microbiota in gastric mucosal atrophy among elderly patients with Helicobacter pylori (HP) infection.

Methods

A total of 210 elderly patients with HP infection from Lishui Second People's Hospital between January 2023 and June 2024 were selected as the study group, and 210 healthy volunteers during the same period served as the control group. The IL-23/Th17 immune-inflammatory axis factors [IL-23, interleukin-17 (IL-17), tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), interleukin-2 (IL-2)], and gut microbiota were compared between the study and control groups. The study group was further divided into an atrophy subgroup (101 cases) and a non-atrophy subgroup (109 cases) based on the presence of gastric mucosal atrophy. Clinical data, IL-23/Th17 immune-inflammatory axis factors, and gut microbiota characteristics were compared between the two subgroups. Logistic regression analysis was used to investigate the influencing factors of gastric mucosal atrophy in elderly patients with HP infection and the interactive effects of the IL-23/Th17 immune-inflammatory axis and gut microbiota. Receiver operating characteristic (ROC) curve and area under the curve (AUC) analyses were performed to assess the predictive value of the IL-23/Th17 immune-inflammatory axis and gut microbiota for gastric mucosal atrophy in elderly patients with HP infection.

Results

The study group had higher serum levels of IL-23, IL-17, TNF-α, IL-6, IL-2, and a higher count of Lactobacillus acidophilus, but lower counts of Bifidobacterium and Lactobacillus compared to the control group (P < 0.05). Within the study group, the atrophy subgroup showed more pronounced differences in these immunological and microbiological parameters compared to the non-atrophy subgroup (all P < 0.05). Logistic regression identified all measured immune factors and gut microbiota as independent influencing factors for gastric mucosal atrophy (all P < 0.05). Significant interactive effects were observed between the IL-23/Th17 axis factors and gut microbiota (all P < 0.05). The combined ROC model incorporating these factors achieved an AUC of 0.908 for predicting gastric mucosal atrophy, significantly outperforming individual predictors (all P < 0.001).

Conclusion

There are significant interactive effects between the IL-23/Th17 immune-inflammatory axis and gut microbiota in gastric mucosal atrophy among elderly patients with HP infection, and the combined predictive value is reliable.
目的:探讨白细胞介素-23 (IL-23)/Th17免疫炎症轴与肠道菌群在老年幽门螺杆菌(HP)感染患者胃粘膜萎缩中的相互作用。方法:选取2023年1月~ 2024年6月在丽水市第二人民医院就诊的老年HP感染患者210例为研究组,同期健康志愿者210例为对照组。比较研究组和对照组的IL-23/Th17免疫炎性轴因子[IL-23、白细胞介素-17 (IL-17)、肿瘤坏死因子-α (TNF-α)、白细胞介素-6 (IL-6)、白细胞介素-2 (IL-2)]和肠道菌群。根据胃黏膜萎缩的存在,将研究组进一步分为萎缩亚组(101例)和非萎缩亚组(109例)。比较两个亚组的临床数据、IL-23/Th17免疫炎症轴因子和肠道菌群特征。采用Logistic回归分析探讨老年HP感染患者胃黏膜萎缩的影响因素及IL-23/Th17免疫炎症轴与肠道菌群的交互作用。采用受试者工作特征(ROC)曲线和曲线下面积(AUC)分析,评估IL-23/Th17免疫炎症轴和肠道菌群对老年HP感染患者胃粘膜萎缩的预测价值。结果:研究组血清IL-23、IL-17、TNF-α、IL-6、IL-2水平高于对照组,嗜酸乳杆菌数量高于对照组,双歧杆菌和乳杆菌数量低于对照组(P < 0.05)。在研究组中,与非萎缩亚组相比,萎缩亚组在这些免疫学和微生物学参数上表现出更显著的差异(均P < 0.05)。Logistic回归分析结果显示,免疫因子和肠道菌群均为胃黏膜萎缩的独立影响因素(P < 0.05)。IL-23/Th17轴因子与肠道菌群之间存在显著交互作用(P < 0.05)。纳入这些因素的联合ROC模型预测胃粘膜萎缩的AUC为0.908,显著优于单个预测因子(均P < 0.001)。结论:IL-23/Th17免疫炎症轴与肠道菌群在老年HP感染患者胃黏膜萎缩中存在显著的交互作用,联合预测价值可靠。
{"title":"Interaction between IL-23/Th17 immune inflammatory axis and intestinal flora in gastric mucosal atrophy caused by Helicobacter pylori infection in the elderly","authors":"Haiping Shen,&nbsp;Shuyuan Zhu,&nbsp;Lingling Ren,&nbsp;Fangling Chen,&nbsp;Chengyong Qian,&nbsp;Xiangcheng Hu,&nbsp;Guanglan Chen","doi":"10.1016/j.imlet.2025.107114","DOIUrl":"10.1016/j.imlet.2025.107114","url":null,"abstract":"<div><h3>Objective</h3><div>To explore the interactive effects of the interleukin-23 (IL-23)/Th17 immune-inflammatory axis and gut microbiota in gastric mucosal atrophy among elderly patients with Helicobacter pylori (HP) infection.</div></div><div><h3>Methods</h3><div>A total of 210 elderly patients with HP infection from Lishui Second People's Hospital between January 2023 and June 2024 were selected as the study group, and 210 healthy volunteers during the same period served as the control group. The IL-23/Th17 immune-inflammatory axis factors [IL-23, interleukin-17 (IL-17), tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), interleukin-2 (IL-2)], and gut microbiota were compared between the study and control groups. The study group was further divided into an atrophy subgroup (101 cases) and a non-atrophy subgroup (109 cases) based on the presence of gastric mucosal atrophy. Clinical data, IL-23/Th17 immune-inflammatory axis factors, and gut microbiota characteristics were compared between the two subgroups. Logistic regression analysis was used to investigate the influencing factors of gastric mucosal atrophy in elderly patients with HP infection and the interactive effects of the IL-23/Th17 immune-inflammatory axis and gut microbiota. Receiver operating characteristic (ROC) curve and area under the curve (AUC) analyses were performed to assess the predictive value of the IL-23/Th17 immune-inflammatory axis and gut microbiota for gastric mucosal atrophy in elderly patients with HP infection.</div></div><div><h3>Results</h3><div>The study group had higher serum levels of IL-23, IL-17, TNF-α, IL-6, IL-2, and a higher count of <em>Lactobacillus acidophilus</em>, but lower counts of Bifidobacterium and Lactobacillus compared to the control group (<em>P</em> &lt; 0.05). Within the study group, the atrophy subgroup showed more pronounced differences in these immunological and microbiological parameters compared to the non-atrophy subgroup (all P &lt; 0.05). Logistic regression identified all measured immune factors and gut microbiota as independent influencing factors for gastric mucosal atrophy (all P &lt; 0.05). Significant interactive effects were observed between the IL-23/Th17 axis factors and gut microbiota (all P &lt; 0.05). The combined ROC model incorporating these factors achieved an AUC of 0.908 for predicting gastric mucosal atrophy, significantly outperforming individual predictors (all P &lt; 0.001).</div></div><div><h3>Conclusion</h3><div>There are significant interactive effects between the IL-23/Th17 immune-inflammatory axis and gut microbiota in gastric mucosal atrophy among elderly patients with HP infection, and the combined predictive value is reliable.</div></div>","PeriodicalId":13413,"journal":{"name":"Immunology letters","volume":"278 ","pages":"Article 107114"},"PeriodicalIF":2.8,"publicationDate":"2025-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145633081","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IL-2/IL-2Ab complexes expand regulatory T cells in vivo and provide neuroprotection after cardiac arrest IL-2/IL-2Ab复合物在体内扩展调节性T细胞并在心脏骤停后提供神经保护
IF 2.8 4区 医学 Q3 IMMUNOLOGY Pub Date : 2025-11-24 DOI: 10.1016/j.imlet.2025.107113
Shan Wu , Xuanyu Chen , XiaoMei Ling , Yunyang Han , Shaomei Chen , Wei Wang
Cardiac arrest (CA) results in global ischemia/reperfusion injury and severe neurological dysfunction, for which effective therapeutic interventions remain limited. Regulatory T cells (Tregs) play a crucial role in modulating post-ischemic inflammation and promoting neuroprotection. In this study, we demonstrate that in vivo expansion of Tregs using the interleukin-2/interleukin-2 antibody (IL-2/IL-2Ab) complex significantly increased Treg numbers in the blood, spleen, and lymph nodes. Mice pretreated with the IL-2/IL-2Ab complex before cardiac arrest and cardiopulmonary resuscitation (CA/CPR) exhibited improved neurological recovery, reduced ischemic brain injury, and enhanced survival rates. These findings highlight a potential immunomodulatory strategy for improving outcomes after cardiac arrest. The IL-2/IL-2Ab complex may represent a promising adjunctive therapy to attenuate post-resuscitation brain injury through the selective expansion of protective Tregs.
心脏骤停(CA)导致全身缺血/再灌注损伤和严重的神经功能障碍,有效的治疗干预措施仍然有限。调节性T细胞(Tregs)在调节缺血后炎症和促进神经保护中起着至关重要的作用。在这项研究中,我们证明了使用白细胞介素-2/白细胞介素-2抗体(IL-2/IL-2Ab)复合物在体内扩增Treg可显著增加血液、脾脏和淋巴结中的Treg数量。在心脏骤停和心肺复苏(CA/CPR)前用IL-2/IL-2Ab复合物预处理的小鼠表现出改善神经恢复,减少缺血性脑损伤和提高生存率。这些发现强调了改善心脏骤停后预后的潜在免疫调节策略。IL-2/IL-2Ab复合体可能是一种很有前途的辅助疗法,通过选择性扩大保护性Tregs来减轻复苏后脑损伤。
{"title":"IL-2/IL-2Ab complexes expand regulatory T cells in vivo and provide neuroprotection after cardiac arrest","authors":"Shan Wu ,&nbsp;Xuanyu Chen ,&nbsp;XiaoMei Ling ,&nbsp;Yunyang Han ,&nbsp;Shaomei Chen ,&nbsp;Wei Wang","doi":"10.1016/j.imlet.2025.107113","DOIUrl":"10.1016/j.imlet.2025.107113","url":null,"abstract":"<div><div>Cardiac arrest (CA) results in global ischemia/reperfusion injury and severe neurological dysfunction, for which effective therapeutic interventions remain limited. Regulatory T cells (Tregs) play a crucial role in modulating post-ischemic inflammation and promoting neuroprotection. In this study, we demonstrate that in vivo expansion of Tregs using the interleukin-2/interleukin-2 antibody (IL-2/IL-2Ab) complex significantly increased Treg numbers in the blood, spleen, and lymph nodes. Mice pretreated with the IL-2/IL-2Ab complex before cardiac arrest and cardiopulmonary resuscitation (CA/CPR) exhibited improved neurological recovery, reduced ischemic brain injury, and enhanced survival rates. These findings highlight a potential immunomodulatory strategy for improving outcomes after cardiac arrest. The IL-2/IL-2Ab complex may represent a promising adjunctive therapy to attenuate post-resuscitation brain injury through the selective expansion of protective Tregs.</div></div>","PeriodicalId":13413,"journal":{"name":"Immunology letters","volume":"278 ","pages":"Article 107113"},"PeriodicalIF":2.8,"publicationDate":"2025-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145632996","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of IgG antibody levels, avidity, and subclass distribution against pertussis toxin in children and adolescents after four-dose primary whole-cell (DTwP) or acellular (DTaP) vaccination, each followed by a single DTaP booster 儿童和青少年接种四剂原代全细胞(DTwP)或脱细胞(DTaP)疫苗后抗百日咳毒素IgG抗体水平、亲和力和亚类分布的比较,每次接种一次DTaP加强剂
IF 2.8 4区 医学 Q3 IMMUNOLOGY Pub Date : 2025-11-24 DOI: 10.1016/j.imlet.2025.107115
Waldemar Rastawicki , Aleksandra Anna Zasada
Vaccination plays a key role in the prevention of pertussis, the infectious disease that is endemic worldwide. Two types of pertussis vaccines are currently in use: whole-cell (wP) and acellular (aP) vaccines. Differences in the duration of immunity have been observed depending on the vaccine type. In this study, the levels of individual IgG subclasses and antibody avidity were assessed in children vaccinated with either aP or wP vaccines. The results revealed no significant differences in the mean IgG antibody levels and avidity between children immunised with wP and those who received aP vaccines. However, in the vaccinated children IgG4 was a dominated IgG subclass, regardless of vaccine used (aP v. wP), whereas in pertussis patients the IgG1 was dominating. These findings need deeper investigation, in terms of a vaccine efficacy and wanning immunity, as typically in response to protein antigens IgG1 is dominating. Moreover, the observation of IgG4 predominance in vaccinated vs. IgG1 predominance in infected individuals might be a valuable parameter in pertussis diagnostics as it enables differentiation between infected and vaccinated but not-infected individuals.
疫苗接种在预防百日咳方面起着关键作用,百日咳是一种世界性的地方性传染病。目前使用的百日咳疫苗有两种:全细胞(wP)和非细胞(aP)疫苗。根据疫苗类型的不同,观察到免疫持续时间的差异。在这项研究中,评估了接种aP或wP疫苗的儿童的个体IgG亚类水平和抗体贪婪度。结果显示,接种wP疫苗和接种aP疫苗的儿童在平均IgG抗体水平和贪婪度方面没有显著差异。然而,在接种疫苗的儿童中,IgG4是占主导地位的IgG亚类,无论使用何种疫苗(aP或wP),而在百日咳患者中,IgG1占主导地位。这些发现需要更深入的研究,就疫苗效力和警告免疫而言,因为通常对蛋白质抗原IgG1的反应是主导的。此外,观察到接种者IgG4的优势与感染者IgG1的优势可能是百日咳诊断的一个有价值的参数,因为它可以区分感染和接种但未感染的个体。
{"title":"Comparison of IgG antibody levels, avidity, and subclass distribution against pertussis toxin in children and adolescents after four-dose primary whole-cell (DTwP) or acellular (DTaP) vaccination, each followed by a single DTaP booster","authors":"Waldemar Rastawicki ,&nbsp;Aleksandra Anna Zasada","doi":"10.1016/j.imlet.2025.107115","DOIUrl":"10.1016/j.imlet.2025.107115","url":null,"abstract":"<div><div>Vaccination plays a key role in the prevention of pertussis, the infectious disease that is endemic worldwide. Two types of pertussis vaccines are currently in use: whole-cell (wP) and acellular (aP) vaccines. Differences in the duration of immunity have been observed depending on the vaccine type. In this study, the levels of individual IgG subclasses and antibody avidity were assessed in children vaccinated with either aP or wP vaccines. The results revealed no significant differences in the mean IgG antibody levels and avidity between children immunised with wP and those who received aP vaccines. However, in the vaccinated children IgG4 was a dominated IgG subclass, regardless of vaccine used (aP v. wP), whereas in pertussis patients the IgG1 was dominating. These findings need deeper investigation, in terms of a vaccine efficacy and wanning immunity, as typically in response to protein antigens IgG1 is dominating. Moreover, the observation of IgG4 predominance in vaccinated vs. IgG1 predominance in infected individuals might be a valuable parameter in pertussis diagnostics as it enables differentiation between infected and vaccinated but not-infected individuals.</div></div>","PeriodicalId":13413,"journal":{"name":"Immunology letters","volume":"278 ","pages":"Article 107115"},"PeriodicalIF":2.8,"publicationDate":"2025-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145623053","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter to the editor: "Importance of BCG vaccination at birth in pediatric patients with chronic granulomatous disease after hematopoietic stem cell transplantation in developing countries" 致编辑的信:“发展中国家造血干细胞移植后慢性肉芽肿病患儿出生时接种卡介苗的重要性”。
IF 2.8 4区 医学 Q3 IMMUNOLOGY Pub Date : 2025-11-23 DOI: 10.1016/j.imlet.2025.107112
Saaz Kumar , Yashpal Jesswani , Manaish Kumar
{"title":"Letter to the editor: \"Importance of BCG vaccination at birth in pediatric patients with chronic granulomatous disease after hematopoietic stem cell transplantation in developing countries\"","authors":"Saaz Kumar ,&nbsp;Yashpal Jesswani ,&nbsp;Manaish Kumar","doi":"10.1016/j.imlet.2025.107112","DOIUrl":"10.1016/j.imlet.2025.107112","url":null,"abstract":"","PeriodicalId":13413,"journal":{"name":"Immunology letters","volume":"278 ","pages":"Article 107112"},"PeriodicalIF":2.8,"publicationDate":"2025-11-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145603906","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dendritic Cells: key controllers of lymphoid tissue organization 树突状细胞:淋巴组织组织的关键控制者。
IF 2.8 4区 医学 Q3 IMMUNOLOGY Pub Date : 2025-11-13 DOI: 10.1016/j.imlet.2025.107111
Alessia Calabrò , Claudia De Pasquale , Fabiana Drommi , Elena Giusto , Silvia Tamburini , Grazia Vento , Sayuri Yamazaki , Stefania Campana , Guido Ferlazzo
Dendritic cells (DCs) are highly efficient antigen-presenting cells that play a central role in inducing and controlling immune responses. Beyond their role in antigen presentation and in orchestrating lymphocyte activities, DCs also contribute to the spatial and functional organization of lymphoid structures, including both secondary and tertiary lymphoid organs, acting at different levels during both lymphoid tissue neogenesis and their maintenance.
DCs can facilitate lymphoid tissue development by interacting with both lymphoid tissue inducer and organizer cells, initiating early aggregation and supporting lymphotoxin-mediated signaling pathways essential for lymphoid structure maturation. Additionally, DCs release chemokines attracting and anchoring immune cells in lymphoid tissues and regulate the formation and the overall size of high endothelial venule system, which mediate immune cell trafficking into lymphoid tissues.
The dynamic crosstalk between DCs and fibroblastic reticular cells (FRC), which facilitate immune cell interactions and compartmentalization, is essential for lymphoid tissue specialization and function, though the precise cellular and molecular mechanisms of DC/FRC crosstalk remain to be fully elucidated.
Finally, studies in mice and humans suggest that DC subsets are pivotal in T follicular helper cell differentiation, essential for humoral immunity in B cell follicles of lymphoid tissues, therefore emphasizing DCs’ critical role also in supporting B cell maturation and antibody responses in the germinal centers of lymphoid organs.
树突状细胞(dc)是一种高效的抗原呈递细胞,在诱导和控制免疫反应中起着重要作用。除了在抗原呈递和协调淋巴细胞活动中发挥作用外,树突状细胞还参与淋巴组织的空间和功能组织,包括二级和三级淋巴器官,在淋巴组织新生和维持过程中发挥不同水平的作用。树突状细胞可以通过与淋巴组织诱导剂和组织者细胞相互作用来促进淋巴组织的发育,启动早期聚集并支持淋巴素介导的淋巴组织结构成熟所必需的信号通路。此外,dc释放趋化因子吸引和锚定淋巴组织中的免疫细胞,调节高内皮小静脉系统的形成和整体大小,介导免疫细胞转运到淋巴组织。DC和成纤维网状细胞(FRC)之间的动态串扰促进了免疫细胞的相互作用和区隔化,对淋巴组织的特化和功能至关重要,尽管DC/FRC串扰的确切细胞和分子机制仍有待充分阐明。最后,对小鼠和人类的研究表明,DC亚群在T滤泡辅助细胞分化中起关键作用,对淋巴组织B细胞滤泡的体液免疫至关重要,因此强调DC在淋巴器官生发中心支持B细胞成熟和抗体反应中的关键作用。
{"title":"Dendritic Cells: key controllers of lymphoid tissue organization","authors":"Alessia Calabrò ,&nbsp;Claudia De Pasquale ,&nbsp;Fabiana Drommi ,&nbsp;Elena Giusto ,&nbsp;Silvia Tamburini ,&nbsp;Grazia Vento ,&nbsp;Sayuri Yamazaki ,&nbsp;Stefania Campana ,&nbsp;Guido Ferlazzo","doi":"10.1016/j.imlet.2025.107111","DOIUrl":"10.1016/j.imlet.2025.107111","url":null,"abstract":"<div><div>Dendritic cells (DCs) are highly efficient antigen-presenting cells that play a central role in inducing and controlling immune responses. Beyond their role in antigen presentation and in orchestrating lymphocyte activities, DCs also contribute to the spatial and functional organization of lymphoid structures, including both secondary and tertiary lymphoid organs, acting at different levels during both lymphoid tissue neogenesis and their maintenance.</div><div>DCs can facilitate lymphoid tissue development by interacting with both lymphoid tissue inducer and organizer cells, initiating early aggregation and supporting lymphotoxin-mediated signaling pathways essential for lymphoid structure maturation. Additionally, DCs release chemokines attracting and anchoring immune cells in lymphoid tissues and regulate the formation and the overall size of high endothelial venule system, which mediate immune cell trafficking into lymphoid tissues.</div><div>The dynamic crosstalk between DCs and fibroblastic reticular cells (FRC), which facilitate immune cell interactions and compartmentalization, is essential for lymphoid tissue specialization and function, though the precise cellular and molecular mechanisms of DC/FRC crosstalk remain to be fully elucidated.</div><div>Finally, studies in mice and humans suggest that DC subsets are pivotal in T follicular helper cell differentiation, essential for humoral immunity in B cell follicles of lymphoid tissues, therefore emphasizing DCs’ critical role also in supporting B cell maturation and antibody responses in the germinal centers of lymphoid organs.</div></div>","PeriodicalId":13413,"journal":{"name":"Immunology letters","volume":"278 ","pages":"Article 107111"},"PeriodicalIF":2.8,"publicationDate":"2025-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145530634","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Addressing the immunological gaps in asthma treatment: A call for region-specific research in Africa 解决哮喘治疗中的免疫学差距:呼吁在非洲开展区域特异性研究。
IF 2.8 4区 医学 Q3 IMMUNOLOGY Pub Date : 2025-11-11 DOI: 10.1016/j.imlet.2025.107110
Zemichael Getu Alemayehu, Brook Lelisa Sime, Abenezer Shiferaw Keraga
{"title":"Addressing the immunological gaps in asthma treatment: A call for region-specific research in Africa","authors":"Zemichael Getu Alemayehu,&nbsp;Brook Lelisa Sime,&nbsp;Abenezer Shiferaw Keraga","doi":"10.1016/j.imlet.2025.107110","DOIUrl":"10.1016/j.imlet.2025.107110","url":null,"abstract":"","PeriodicalId":13413,"journal":{"name":"Immunology letters","volume":"277 ","pages":"Article 107110"},"PeriodicalIF":2.8,"publicationDate":"2025-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145512572","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anti-Yo antibody associated axial movement disorders – a novel phenotype in ANNS 抗yo抗体相关轴向运动障碍- ANNS的一种新表型。
IF 2.8 4区 医学 Q3 IMMUNOLOGY Pub Date : 2025-11-07 DOI: 10.1016/j.imlet.2025.107109
Ajith Cherian , Divya K P , Amod R , Deepa K P

Background

Movement disorders, as an anti-neuronal antibody mediated neurological syndrome(ANNS), is usually associated with anti-CV2/CRMP5,Hu/ANNA1 and Contactin-associated protein-like 2 (CASPR2) antibodies. Anti-Yo antibody associated movement disorders are extremely rare.

Methods

We analysed the data of 47 patients with anti –Yo antibodies who presented over a period of 5 years (2019–2024) in a tertiary care institute. Those with movement disorder phenotype, without ataxia, were included. Other etiologies were excluded with relevant work up.

Results

We report two elderly males in their sixties who presented with a subacute onset isolated progressive axial movement disorders, with positive anti-Yo antibody. One patient with axial myoclonus and camptocormia who did not initially respond to intravenous methylprednisolone had remarkable improvement with intravenous immunoglobulin and rituximab, while in the other treatment response was suboptimal.

Conclusion

Movement disorders due to anti-neuronal antibodies should be suspected when they develop subacutely, in older patients (> 50 years), have a progressive course beyond 3 months, associated with pain and constitutional symptoms like weight loss, all of which were present in our cases. Such intracellular Yo antigen induced ANNS usually have guarded response to immunomodulatory therapy compared to those mediated by antibodies against surface antigens, though one patient of ours had a remarkable improvement.
背景:运动障碍作为一种抗神经元抗体介导的神经综合征(ANNS),通常与抗cv2 /CRMP5、Hu/ANNA1和接触蛋白相关蛋白样2 (CASPR2)抗体相关。抗- yo抗体相关的运动障碍极为罕见。方法:我们分析了一家三级医疗机构5年(2019-2024)期间47例抗yo抗体患者的数据。包括运动障碍表型,无共济失调的患者。其他病因经相关工作排除。结果:我们报告了两名60多岁的老年男性,他们表现为亚急性发作的孤立进行性轴向运动障碍,抗yo抗体阳性。一名轴型肌阵挛和喜树病患者最初对静脉注射甲基强的松龙没有反应,但在静脉注射免疫球蛋白和利妥昔单抗后,情况有了显著改善,而在另一种治疗中,反应则不理想。结论:抗神经元抗体引起的运动障碍在发生亚急性时应予以怀疑,在老年患者(50岁以上)中,病程进展超过3个月,伴有疼痛和体重减轻等体质症状,所有这些都出现在我们的病例中。这种细胞内Yo抗原诱导的ANNS与表面抗原抗体介导的ANNS相比,通常对免疫调节治疗有保护反应,尽管我们的一位患者有显着改善。
{"title":"Anti-Yo antibody associated axial movement disorders – a novel phenotype in ANNS","authors":"Ajith Cherian ,&nbsp;Divya K P ,&nbsp;Amod R ,&nbsp;Deepa K P","doi":"10.1016/j.imlet.2025.107109","DOIUrl":"10.1016/j.imlet.2025.107109","url":null,"abstract":"<div><h3>Background</h3><div>Movement disorders, as an anti-neuronal antibody mediated neurological syndrome(ANNS), is usually associated with anti-CV2/CRMP5,Hu/ANNA1 and Contactin-associated protein-like 2 (CASPR2) antibodies. Anti-Yo antibody associated movement disorders are extremely rare.</div></div><div><h3>Methods</h3><div>We analysed the data of 47 patients with anti –Yo antibodies who presented over a period of 5 years (2019–2024) in a tertiary care institute. Those with movement disorder phenotype, without ataxia, were included. Other etiologies were excluded with relevant work up.</div></div><div><h3>Results</h3><div>We report two elderly males in their sixties who presented with a subacute onset isolated progressive axial movement disorders, with positive anti-Yo antibody. One patient with axial myoclonus and camptocormia who did not initially respond to intravenous methylprednisolone had remarkable improvement with intravenous immunoglobulin and rituximab, while in the other treatment response was suboptimal.</div></div><div><h3>Conclusion</h3><div>Movement disorders due to anti-neuronal antibodies should be suspected when they develop subacutely, in older patients (&gt; 50 years), have a progressive course beyond 3 months, associated with pain and constitutional symptoms like weight loss, all of which were present in our cases. Such intracellular Yo antigen induced ANNS usually have guarded response to immunomodulatory therapy compared to those mediated by antibodies against surface antigens, though one patient of ours had a remarkable improvement.</div></div>","PeriodicalId":13413,"journal":{"name":"Immunology letters","volume":"277 ","pages":"Article 107109"},"PeriodicalIF":2.8,"publicationDate":"2025-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145481997","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Siglec-1+ macrophages in anti-tumor immunity siglec1 +巨噬细胞在抗肿瘤免疫中的作用
IF 2.8 4区 医学 Q3 IMMUNOLOGY Pub Date : 2025-11-06 DOI: 10.1016/j.imlet.2025.107108
François-Xavier Mauvais , Peter van Endert
Macrophages expressing the sialic acid-binding lectin Siglec-1 are positioned strategically for uptake and filtering of antigenic material circulating through the lymphatic system into the subcapsular sinus of lymph nodes and through the blood into the marginal zone of the spleen. Siglec-1+ macrophages are also found in many tissues, frequently displaying an inflammatory profile. In secondary lymphoid organs, these cells are strategically positioned and play a role in adaptive immune responses by B, NK and T lymphocytes. A potential role of the cells in antitumor immunity has attracted significant scientific interest. This concept is supported by a report of dendritic cell-independent priming of a protective antitumor response by lymph node Siglec-1+ macrophages. Indeed, examination of preclinical models and human tumors has provided evidence for a dominant protective effect of lymph node Siglec-1+ macrophages in major types of solid tumors e.g. breast or colorectal cancer. In contrast, Siglec-1+ macrophages within tumor tissue have been found to be associated variably with favorable or unfavorable outcome depending on the model and tumor studied. We have recently demonstrated in mouse models that splenic Siglec-1+ macrophages in themarginal zone can prime protective tumor immunity against both tumors disseminating through the blood and tumors invading the spleen in the absence of type 1 conventional dendritic cells. Considering this, we postulate Siglec-1+ macrophages in all secondary lymphoid organs can prime potent antitumor responses. We propose that this capacity could be exploited for therapeutic stimulation of tumor immunity.
巨噬细胞表达唾液酸结合凝集素siglec1,通过淋巴系统进入淋巴结的包膜下窦,并通过血液进入脾脏边缘区,从而有策略地摄取和过滤抗原物质。siglec1 +巨噬细胞也存在于许多组织中,经常表现出炎症特征。在次级淋巴器官中,这些细胞被战略性地定位并在B、NK和T淋巴细胞的适应性免疫应答中发挥作用。这些细胞在抗肿瘤免疫中的潜在作用已经引起了科学界的极大兴趣。这一概念得到了淋巴结siglec1 +巨噬细胞不依赖树突状细胞启动保护性抗肿瘤反应的报道的支持。事实上,临床前模型和人类肿瘤的研究已经提供了证据,证明淋巴结siglec1 +巨噬细胞在主要类型的实体肿瘤(如乳腺癌或结直肠癌)中具有主要的保护作用。相反,肿瘤组织内的siglec1 +巨噬细胞根据所研究的模型和肿瘤,与有利或不利的结果有不同的相关性。我们最近在小鼠模型中证明,在没有1型常规树突状细胞的情况下,脾脏边缘区siglec1 +巨噬细胞可以对肿瘤通过血液传播和肿瘤侵入脾脏产生保护性肿瘤免疫。考虑到这一点,我们假设所有次级淋巴器官中的siglec1 +巨噬细胞都能引发有效的抗肿瘤反应。我们建议这种能力可以用于肿瘤免疫的治疗性刺激。
{"title":"Siglec-1+ macrophages in anti-tumor immunity","authors":"François-Xavier Mauvais ,&nbsp;Peter van Endert","doi":"10.1016/j.imlet.2025.107108","DOIUrl":"10.1016/j.imlet.2025.107108","url":null,"abstract":"<div><div>Macrophages expressing the sialic acid-binding lectin Siglec-1 are positioned strategically for uptake and filtering of antigenic material circulating through the lymphatic system into the subcapsular sinus of lymph nodes and through the blood into the marginal zone of the spleen. Siglec-1<sup>+</sup> macrophages are also found in many tissues, frequently displaying an inflammatory profile. In secondary lymphoid organs, these cells are strategically positioned and play a role in adaptive immune responses by B, NK and T lymphocytes. A potential role of the cells in antitumor immunity has attracted significant scientific interest. This concept is supported by a report of dendritic cell-independent priming of a protective antitumor response by lymph node Siglec-1+ macrophages. Indeed, examination of preclinical models and human tumors has provided evidence for a dominant protective effect of lymph node Siglec-1+ macrophages in major types of solid tumors e.g. breast or colorectal cancer. In contrast, Siglec-1+ macrophages within tumor tissue have been found to be associated variably with favorable or unfavorable outcome depending on the model and tumor studied. We have recently demonstrated in mouse models that splenic Siglec-1+ macrophages in themarginal zone can prime protective tumor immunity against both tumors disseminating through the blood and tumors invading the spleen in the absence of type 1 conventional dendritic cells. Considering this, we postulate Siglec-1+ macrophages in all secondary lymphoid organs can prime potent antitumor responses. We propose that this capacity could be exploited for therapeutic stimulation of tumor immunity.</div></div>","PeriodicalId":13413,"journal":{"name":"Immunology letters","volume":"277 ","pages":"Article 107108"},"PeriodicalIF":2.8,"publicationDate":"2025-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145476772","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PLIN2 exacerbates Allergic Rhinitis by inhibiting PINK1/Parkin-mediated mitophagy PLIN2通过抑制PINK1/ parkin介导的线粒体自噬而加重变应性鼻炎。
IF 2.8 4区 医学 Q3 IMMUNOLOGY Pub Date : 2025-11-03 DOI: 10.1016/j.imlet.2025.107107
Wangbo Yu , Shuai Zhang , Lijuan Peng , Jingwei Du

Objective

To investigate the pro-inflammatory role and underlying mechanism of Perilipin 2 (PLIN2) in Allergic Rhinitis (AR), focusing on its regulation of PINK1/Parkin-mediated mitophagy and the subsequent impact on lipid metabolism and oxidative stress.

Methods

Single-cell RNA sequencing (scRNA-seq) analysis was performed using GSE261706 from the GEO database, involving nasal mucosa from AR patients and healthy controls. A murine AR model was induced by ovalbumin (OVA), and human nasal epithelial cells (HNEpCs) were stimulated with Der p1. Interventions included AAV-mediated PLIN2 knockdown in vivo and siRNA-mediated knockdown in vitro. Techniques included Western blotting, qRT-PCR, flow cytometry, ELISA, and immunofluorescence/histological staining to assess PLIN2 expression, mitophagy, lipid accumulation, oxidative stress, and inflammatory responses.

Results

scRNA-seq analysis identified PLIN2 as a significantly upregulated gene in AR epithelial cells, which correlated with dysfunctional autophagy pathways. In both OVA-induced mice and Der p1-treated HNEpCs, PLIN2 expression was significantly elevated, accompanied by inhibited mitophagy (decreased LC3-II/I ratio, reduced PINK1/Parkin levels, and p62 accumulation), increased lipid deposition, and elevated ROS levels. PLIN2 knockdown markedly ameliorated AR pathology in mice, reducing inflammatory infiltration and serum levels of IgE, IL-4, and IL-5. Mechanistically, PLIN2 knockdown restored PINK1/Parkin-mediated mitophagy, decreased lipid accumulation, and attenuated ROS-induced cellular damage in HNEpCs.

Conclusions

PLIN2 exacerbates AR pathogenesis by inhibiting PINK1/Parkin-mediated mitophagy, promoting lipid accumulation and oxidative stress, and ultimately causing cellular damage in nasal epithelial cells. PLIN2 acts as a pivotal mediator linking metabolic dysregulation to inflammation, highlighting it as a promising therapeutic target for AR treatment.
目的:探讨Perilipin 2 (PLIN2)在变应性鼻炎(AR)中的促炎作用及其机制,重点研究其对PINK1/ parkin介导的线粒体自噬的调控及其对脂质代谢和氧化应激的影响。方法:使用GEO数据库中的GSE261706进行单细胞RNA测序(scRNA-seq)分析,研究对象为AR患者和健康对照组的鼻黏膜。用卵清蛋白(OVA)诱导小鼠AR模型,用Der p1刺激人鼻上皮细胞(HNEpCs)。干预包括体内aav介导的PLIN2敲低和体外sirna介导的PLIN2敲低。技术包括Western blotting、qRT-PCR、流式细胞术、ELISA和免疫荧光/组织学染色来评估PLIN2的表达、线粒体自噬、脂质积累、氧化应激和炎症反应。结果:scRNA-seq分析发现,PLIN2在AR上皮细胞中表达显著上调,与功能失调的自噬通路相关。在ova诱导小鼠和Der p1处理的HNEpCs中,PLIN2表达显著升高,同时线粒体自噬受到抑制(LC3-II/I比值降低,PINK1/Parkin水平降低,p62积累减少),脂质沉积增加,ROS水平升高。PLIN2敲低可显著改善小鼠AR病理,降低炎症浸润和血清IgE、IL-4和IL-5水平。在机制上,PLIN2敲低恢复了PINK1/ parkin介导的有丝分裂,减少了脂质积累,减轻了ros诱导的HNEpCs细胞损伤。结论:PLIN2通过抑制PINK1/ parkinson介导的线粒体自噬,促进脂质积累和氧化应激,最终导致鼻上皮细胞损伤,从而加剧AR的发病机制。PLIN2作为连接代谢失调和炎症的关键介质,突出表明它是AR治疗的一个有希望的治疗靶点。
{"title":"PLIN2 exacerbates Allergic Rhinitis by inhibiting PINK1/Parkin-mediated mitophagy","authors":"Wangbo Yu ,&nbsp;Shuai Zhang ,&nbsp;Lijuan Peng ,&nbsp;Jingwei Du","doi":"10.1016/j.imlet.2025.107107","DOIUrl":"10.1016/j.imlet.2025.107107","url":null,"abstract":"<div><h3>Objective</h3><div>To investigate the pro-inflammatory role and underlying mechanism of Perilipin 2 (PLIN2) in Allergic Rhinitis (AR), focusing on its regulation of PINK1/Parkin-mediated mitophagy and the subsequent impact on lipid metabolism and oxidative stress.</div></div><div><h3>Methods</h3><div>Single-cell RNA sequencing (scRNA-seq) analysis was performed using GSE261706 from the GEO database, involving nasal mucosa from AR patients and healthy controls. A murine AR model was induced by ovalbumin (OVA), and human nasal epithelial cells (HNEpCs) were stimulated with Der p1. Interventions included AAV-mediated PLIN2 knockdown in vivo and siRNA-mediated knockdown in vitro. Techniques included Western blotting, qRT-PCR, flow cytometry, ELISA, and immunofluorescence/histological staining to assess PLIN2 expression, mitophagy, lipid accumulation, oxidative stress, and inflammatory responses.</div></div><div><h3>Results</h3><div>scRNA-seq analysis identified PLIN2 as a significantly upregulated gene in AR epithelial cells, which correlated with dysfunctional autophagy pathways. In both OVA-induced mice and Der p1-treated HNEpCs, PLIN2 expression was significantly elevated, accompanied by inhibited mitophagy (decreased LC3-II/I ratio, reduced PINK1/Parkin levels, and p62 accumulation), increased lipid deposition, and elevated ROS levels. PLIN2 knockdown markedly ameliorated AR pathology in mice, reducing inflammatory infiltration and serum levels of IgE, IL-4, and IL-5. Mechanistically, PLIN2 knockdown restored PINK1/Parkin-mediated mitophagy, decreased lipid accumulation, and attenuated ROS-induced cellular damage in HNEpCs.</div></div><div><h3>Conclusions</h3><div>PLIN2 exacerbates AR pathogenesis by inhibiting PINK1/Parkin-mediated mitophagy, promoting lipid accumulation and oxidative stress, and ultimately causing cellular damage in nasal epithelial cells. PLIN2 acts as a pivotal mediator linking metabolic dysregulation to inflammation, highlighting it as a promising therapeutic target for AR treatment.</div></div>","PeriodicalId":13413,"journal":{"name":"Immunology letters","volume":"278 ","pages":"Article 107107"},"PeriodicalIF":2.8,"publicationDate":"2025-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145451700","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Human B-lymphopoiesis: Clinical challenges in B cell reconstitution and advances in in vitro modeling 人B淋巴系统:B细胞重建的临床挑战和体外模型的进展。
IF 2.8 4区 医学 Q3 IMMUNOLOGY Pub Date : 2025-11-03 DOI: 10.1016/j.imlet.2025.107106
Franziska Maria Schmidt , Marta Rizzi
The B cell compartment is maintained by continuous replenishment from hematopoietic stem cells (HSCs) and multipotent progenitors, as well as from B cell precursors. B cell depletion is a common therapeutic approach, not only in the context of B cell malignancies, but also in autoimmunity. The targeted elimination of B cells can be achieved through the use of chimeric antigen receptor (CAR)-T cells or monoclonal antibodies or bispecific antibodies that target both B and NK cells or B and T cells. When B cells are depleted, repopulation from bone marrow precursors occurs within three months to one year, following ontogeny. Nevertheless, prolonged B cell aplasia is observed in some patients and is associated with a progressive reduction of serum immunoglobulins and an increased susceptibility to infections. The mechanisms underlying such defects in B cell replenishment remain to be fully elucidated and studies on human B lymphopoiesis are needed in this context. Mouse models can be helpful in studying mechanisms of B cell development and the role of multiple (B cell-specific) genes in this process; however, they do not always mirror the human developmental dynamics and signals. Hence further tools are needed to study human B lymphopoiesis defects. In this review, we summarize the reported studies and cases of prolonged B cell aplasia following B cell depletion and discuss potential underlying causes. We then provide a comprehensive overview of the various in vitro models that can be used to study the dynamic of B lymphopoiesis to dissect B cell developmental defects in humans.
B细胞室由造血干细胞(hsc)和多能祖细胞以及B细胞前体的持续补充维持。B细胞消耗是一种常见的治疗方法,不仅在B细胞恶性肿瘤的背景下,而且在自身免疫。靶向消除B细胞可以通过使用嵌合抗原受体(CAR)-T细胞或针对B和NK细胞或B和T细胞的单克隆抗体或双特异性抗体来实现。当B细胞被耗尽时,在个体发生后的三个月到一年内,骨髓前体会发生再生。然而,在一些患者中观察到延长的B细胞发育不全,并与血清免疫球蛋白的进行性降低和对感染的易感性增加有关。这种B细胞补充缺陷的机制仍有待充分阐明,在这种背景下需要对人类B淋巴生成进行研究。小鼠模型有助于研究B细胞发育机制和多个(B细胞特异性)基因在这一过程中的作用;然而,它们并不总是反映人类发展的动态和信号。因此,需要进一步的工具来研究人类B淋巴系统缺陷。在这篇综述中,我们总结了B细胞耗竭后延长B细胞发育不全的研究报告和病例,并讨论了可能的潜在原因。然后,我们提供了各种体外模型的全面概述,这些模型可用于研究B淋巴生成的动态,以解剖人类B细胞发育缺陷。
{"title":"Human B-lymphopoiesis: Clinical challenges in B cell reconstitution and advances in in vitro modeling","authors":"Franziska Maria Schmidt ,&nbsp;Marta Rizzi","doi":"10.1016/j.imlet.2025.107106","DOIUrl":"10.1016/j.imlet.2025.107106","url":null,"abstract":"<div><div>The B cell compartment is maintained by continuous replenishment from hematopoietic stem cells (HSCs) and multipotent progenitors, as well as from B cell precursors. B cell depletion is a common therapeutic approach, not only in the context of B cell malignancies, but also in autoimmunity. The targeted elimination of B cells can be achieved through the use of chimeric antigen receptor (CAR)-T cells or monoclonal antibodies or bispecific antibodies that target both B and NK cells or B and T cells. When B cells are depleted, repopulation from bone marrow precursors occurs within three months to one year, following ontogeny. Nevertheless, prolonged B cell aplasia is observed in some patients and is associated with a progressive reduction of serum immunoglobulins and an increased susceptibility to infections. The mechanisms underlying such defects in B cell replenishment remain to be fully elucidated and studies on human B lymphopoiesis are needed in this context. Mouse models can be helpful in studying mechanisms of B cell development and the role of multiple (B cell-specific) genes in this process; however, they do not always mirror the human developmental dynamics and signals. Hence further tools are needed to study human B lymphopoiesis defects. In this review, we summarize the reported studies and cases of prolonged B cell aplasia following B cell depletion and discuss potential underlying causes. We then provide a comprehensive overview of the various <em>in vitro</em> models that can be used to study the dynamic of B lymphopoiesis to dissect B cell developmental defects in humans.</div></div>","PeriodicalId":13413,"journal":{"name":"Immunology letters","volume":"277 ","pages":"Article 107106"},"PeriodicalIF":2.8,"publicationDate":"2025-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145451722","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Immunology letters
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1